Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Angitia Biopharmaceuticals

Clinical trials sponsored by Angitia Biopharmaceuticals, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New Bone-Boosting drug shows promise for osteoporosis Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1 Terminated 1

New Bone-Boosting drug shows promise for osteoporosis

Disease control Ongoing

This study tests an experimental drug called AGA2118 in postmenopausal women aged 55 to 80 who have low bone density but no history of fractures. The goal is to see if the drug can safely increase bone mineral density over 12 months compared to a placebo. About 379 women will par…

Phase 2 • Sponsor: Angitia Biopharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 09:03 UTC